Module 8

Objectives

This Health Professionals Learning Module will provide an overview of oral therapies currently available and discuss the current standard management.
Neil will be discussing the different oral agents used in lymphoma, oral agents in the pipeline and some of the challenges with oral therapies.

This presentation is Session #1 in a 2 part series. Session #2 will be held in late November 2021.

Module 8 presentation

Lymphoma and Oral Therapies

Presented by Neil Lam
Oncology Pharmacist – Clinical Lead Icon Cancer Centre Wesley

Neil is the Cancer Pharmacist (Clinical Lead) at Icon Cancer Centre Wesley in Brisbane. Following his Pharmacy training, he completed a Master’s degree in Medical Science (Drug Development) and undertook certification in Geriatric Pharmacy (BCGP).

Over the past 20 years, he has worked in regulatory affairs, community pharmacy, sterile production and cancer services in the day hospital setting. His areas of interest include pharmaceutics and medication safety of cancer treatment. He is passionate about continuing professional education.

Post assessment & feedback survey

To be eligible for a certificate of attendance, you need to complete a short assessment. The certificate will be emailed to you shortly after you have submitted the assessment.

Further reading and resources

Below is a list of additional readings on oral therapies in Lymphoma/ CLL. 

  1. Novel targets in Aggressive Lymphoma Haematology, ASH education program, 2020

  2. New agents and regimes for diffuse large B cell lymphoma Journal of Haematology and Oncology, 2020

  3. Emerging Therapies in Mantle Cell Lymphoma 
    Journal of Haematology and Oncology, 2020

 

Support and information

Sign up to our Newsletter

Copyright © 2022. Lymphoma Australia
Share This

Newsletter Sign Up

Contact Lymphoma Australia Today!